{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T02:18:23Z","timestamp":1795141103750,"version":"4.10.3"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To evaluate plasma and aqueous humor angiotensin-converting enzyme (ACE) and transforming growth factor-\u03b21 (TGF-\u03b21) levels in patients with proliferative vitreoretinopathy (PVR) secondary to rhegmatogenous retinal detachment (RRD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Eighty-eight patients were divided into three groups: RRD without PVR (non-PVR, n = 36), RRD with PVR (PVR, n = 32), and controls (n = 20). Plasma and aqueous ACE and TGF-\u03b21 levels were quantified using ELISA. Group comparisons, regression, and receiving operating characteristics analyses were performed to determine associations with PVR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Age and sex did not differ among groups (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &gt; 0.05). Median aqueous ACE levels were significantly higher in PVR and non-PVR eyes than in controls (both\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), although the PVR\u2013non-PVR difference was nonsignificant (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.411). Aqueous TGF-\u03b21 levels were markedly elevated in the PVR group versus both others (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). Plasma ACE and TGF-\u03b21 did not differ among groups (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &gt; 0.05). Aqueous TGF-\u03b21 demonstrated strong discriminative performance for PVR within this cohort (area under the curve = 0.92; cutoff 132.0 ng\/L; sensitivity 93.8%; specificity 72.2%). Multivariate analysis identified aqueous TGF-\u03b21 (OR = 1.047,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.002) and symptom duration &gt;30 days (OR = 77.6,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.014) as independent predictors. Aqueous ACE and TGF-\u03b21 were positively correlated, although this association did not reach statistical significance (\u03c1 = 0.230,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.059).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Aqueous ACE and TGF-\u03b21 levels were elevated in eyes with RRD. TGF-\u03b21 was significantly associated with PVR, whereas ACE elevation appeared to reflect intraocular changes related to RRD rather than a PVR-specific process.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/iae.0000000000004885","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T14:23:40Z","timestamp":1779200620000},"page":"1554-1561","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["AQUEOUS HUMOR ANGIOTENSIN-CONVERTING ENZYME AND TGF-\u03b21 LEVELS IN PROLIFERATIVE VITREORETINOPATHY"],"prefix":"10.1097","volume":"46","author":[{"given":"Nurullah","family":"Ko\u00e7ak","sequence":"first","affiliation":[{"name":"Ophthalmology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"\u00d6zdemir","sequence":"additional","affiliation":[{"name":"Ophthalmology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mertcan","family":"Esenkaya","sequence":"additional","affiliation":[{"name":"Ophthalmology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahattin","family":"Avc\u0131","sequence":"additional","affiliation":[{"name":"Biochemistry, Ondokuzmay\u0131s University Hospital, Atakum, Samsun, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261120","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1350-9462(01)00023-4","article-title":"Proliferative vitreoretinopathy: risk factors and pathobiology","volume":"21","author":"Pastor","year":"2002","journal-title":"Prog Retin Eye Res"},{"key":"R2-20261120","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/sj.eye.6700194","article-title":"Proliferative vitreoretinopathy-developments in adjunctive treatment and retinal pathology","volume":"16","author":"Charteris","year":"2002","journal-title":"Eye (Lond)"},{"key":"R3-20261120","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1080\/08164622.2022.2133596","article-title":"Predictive values of systemic inflammation biomarkers in proliferative vitreoretinopathy associated with primary rhegmatogenous retinal detachment","volume":"106","author":"Ko\u00e7ak","year":"2023","journal-title":"Clin Exp Optom"},{"key":"R4-20261120","doi-asserted-by":"crossref","first-page":"e0122229","DOI":"10.1371\/journal.pone.0122229","article-title":"TGF-\u03b21 induced transdifferentiation of rpe cells is mediated by TAK1","volume":"10","author":"Dvashi","year":"2015","journal-title":"PLoS One"},{"key":"R5-20261120","doi-asserted-by":"crossref","first-page":"1060087","DOI":"10.3389\/fopht.2022.1060087","article-title":"Molecular mechanisms of TGF\u03b2-mediated EMT of retinal pigment epithelium in subretinal fibrosis of age-related macular degeneration","volume":"2","author":"Higashijima","year":"2022","journal-title":"Front Ophthalmol (Lausanne)"},{"key":"R6-20261120","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1136\/bjophthalmol-2012-302636","article-title":"Profibrotic cytokines in aqueous humour correlate with aqueous flare in patients with rhegmatogenous retinal detachment","volume":"97","author":"Hoerster","year":"2013","journal-title":"Br J Ophthalmol"},{"key":"R7-20261120","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00417-013-2377-5","article-title":"Upregulation of TGF-\u00df1 in experimental proliferative vitreoretinopathy is accompanied by epithelial to mesenchymal transition","volume":"252","author":"Hoerster","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R8-20261120","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1159\/000081633","article-title":"Immunohistochemical localization of angiotensin-converting enzyme, angiotensin II and AT1 receptor in human ocular tissues","volume":"36","author":"Savaskan","year":"2004","journal-title":"Ophthalmic Res"},{"key":"R9-20261120","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/bjo.86.3.311","article-title":"Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy","volume":"86","author":"Funatsu","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"R10-20261120","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.cardiores.2007.02.008","article-title":"TGF-beta signaling in vascular fibrosis","volume":"74","author":"Ruiz-Ortega","year":"2007","journal-title":"Cardiovasc Res"},{"key":"R11-20261120","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/hy09t1.094234","article-title":"Angiotensin II and renal fibrosis","volume":"38","author":"Mezzano","year":"2001","journal-title":"Hypertension"},{"key":"R12-20261120","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ndt\/gfi265","article-title":"Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases","volume":"21","author":"Ruiz-Ortega","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"R13-20261120","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0031-6997(24)01434-0","article-title":"Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases","volume":"52","author":"Kim","year":"2000","journal-title":"Pharmacol Rev"},{"key":"R14-20261120","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1258\/ebm.2011.010375","article-title":"The role of the renin-angiotensin system in liver fibrosis","volume":"236","author":"Munshi","year":"2011","journal-title":"Exp Biol Med (Maywood)"},{"key":"R15-20261120","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1042\/CS20241204","article-title":"Angiotensin II-induced cardiac fibrosis and dysfunction are exacerbated by deletion of cGKI in periostin+ myofibroblasts","volume":"139","author":"Santos","year":"2025","journal-title":"Clin Sci (Lond)"},{"key":"R16-20261120","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1183\/09031936.00130310","article-title":"Renin is an angiotensin-independent profibrotic mediator: role in pulmonary fibrosis","volume":"39","author":"Montes","year":"2012","journal-title":"Eur Respir J"},{"key":"R17-20261120","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3109\/02713680903484242","article-title":"Plasma and aqueous humor angiotensin-converting enzyme levels in patients with diabetic retinopathy","volume":"35","author":"Aydin","year":"2010","journal-title":"Curr Eye Res"},{"key":"R18-20261120","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1007\/s00417-017-3707-9","article-title":"The influence of systemic renin-angiotensin-inhibition on ocular cytokines related to proliferative vitreoretinopathy","volume":"255","author":"Hoerster","year":"2017","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R19-20261120","first-page":"240","article-title":"Losartan inhibits epithelial-mesenchymal transition in human retinal pigment epithelium cells: potential therapeutic strategy for PVR","volume":"66","author":"Oliver","year":"2025","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R20-20261120","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1089\/jop.2024.0200","article-title":"Topical losartan in the management of corneal scarring fibrosis: update on dosage, efficacy, and potential epithelial toxicity","volume":"41","author":"Dutra","year":"2025","journal-title":"J Ocul Pharmacol Ther"},{"key":"R21-20261120","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00417-024-06710-8","article-title":"Topical losartan ophthalmic drops\u2013a review of corneal wound healing and topical losartan for managing corneal haze and potential future indications","volume":"263","author":"Abdelghaffar","year":"2025","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R22-20261120","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1097\/ICO.0000000000003527","article-title":"Topical losartan for treating corneal haze after Ultraviolet-A\/Riboflavin collagen cross-linking","volume":"43","author":"Rodgers","year":"2024","journal-title":"Cornea"},{"key":"R23-20261120","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0002-9394(14)76695-4","article-title":"An updated classification of retinal detachment with proliferative vitreoretinopathy","volume":"112","author":"Machemer","year":"1991","journal-title":"Am J Ophthalmol"},{"key":"R24-20261120","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/sj.eye.6702498","article-title":"Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion","volume":"22","author":"Noma","year":"2008","journal-title":"Eye (Lond)"},{"key":"R25-20261120","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00417-004-0950-7","article-title":"Aqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patients","volume":"243","author":"Funatsu","year":"2005","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R26-20261120","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1089\/jop.2022.0174","article-title":"Topical losartan: practical guidance for clinical trials in the prevention and treatment of corneal scarring fibrosis and other eye diseases and disorders","volume":"39","author":"Wilson","year":"2023","journal-title":"J Ocul Pharmacol Ther"},{"key":"R27-20261120","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/ICO.0000000000003783","article-title":"Topical losartan for corneal fibrosis: a case series with densitometry analysis","volume":"45","author":"Burgos-Blasco","year":"2026","journal-title":"Cornea"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/IAE.0000000000004885","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T02:00:20Z","timestamp":1795140020000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/IAE.0000000000004885"}},"subtitle":["A Prospective Clinical Study"],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000004885","relation":{},"ISSN":["0275-004X","1539-2864"],"issn-type":[{"value":"0275-004X","type":"print"},{"value":"1539-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]}}}